Immunosuppressive drugs and COVID-19: a review
TS Schoot, APM Kerckhoffs, LB Hilbrands… - Frontiers in …, 2020 - frontiersin.org
Background Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). It is currently unknown whether …
syndrome coronavirus 2 (SARS-CoV-2). It is currently unknown whether …
Immunomodulatory drugs in the management of SARS-CoV-2
DR Burrage, S Koushesh, N Sofat - Frontiers in immunology, 2020 - frontiersin.org
With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain …
Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain …
Pharmaco-immunomodulatory therapy in COVID-19
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
[HTML][HTML] Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
B Russell, C Moss, G George, A Santaolalla… - …, 2020 - ncbi.nlm.nih.gov
Background Cancer and transplant patients with COVID-19 have a higher risk of developing
severe and even fatal respiratory diseases, especially as they may be treated with immune …
severe and even fatal respiratory diseases, especially as they may be treated with immune …
Drug repurposing and cytokine management in response to COVID-19: A review
L Heimfarth, MR Serafini, PR Martins-Filho… - International …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), the infectious disease caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an aggressive disease …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an aggressive disease …
[HTML][HTML] Mechanism and adverse effects of COVID-19 drugs: a basic review
NM Zadeh, NSM Asl, K Forouharnejad… - … journal of physiology …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 …
A review of treatment of coronavirus disease 2019 (COVID-19): Therapeutic repurposing and unmet clinical needs
For the initial phase of pandemic of coronavirus disease 2019 (COVID-19), repurposing
drugs that in vitro inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …
drugs that in vitro inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …
Potential antiviral drugs for SARS-Cov-2 treatment: preclinical findings and ongoing clinical research
S Bimonte, A Crispo, A Amore, E Celentano, A Cuomo… - in vivo, 2020 - iv.iiarjournals.org
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), initially termed 2019-new
CoV (2019-nCoV), is a novel coronavirus responsible for the severe respiratory illness …
CoV (2019-nCoV), is a novel coronavirus responsible for the severe respiratory illness …
Efficacy of COVID-19 treatments: a Bayesian network meta-analysis of randomized controlled trials
Background: We provided a comprehensive evaluation of efficacy of available treatments for
coronavirus disease 2019 (COVID-19). Methods: We searched for candidate COVID-19 …
coronavirus disease 2019 (COVID-19). Methods: We searched for candidate COVID-19 …
[HTML][HTML] Recent insight into SARS-CoV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19
As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great
effort is being made to understand the disease pathogenesis and host factors that …
effort is being made to understand the disease pathogenesis and host factors that …